Newsticker Rewind – March 20, 2013

03.20.2013

In case you missed these posts or would like another look; here’s a recap of some Newsticker links (the left hand column) and original posts from the past month. Cardinal Health agrees to buy Twinsburg-based AssuraMed A new name for the Medical Mart in Cleveland Cleveland Clinic secures NIH grant for autism research New president [...]

Read the full article →

Nationwide Children’s Center for Gene Therapy awarded $3.7 million grant

03.15.2013

A three-year, $3,752,462 cooperative agreement from the National Institute of Neurological Disorders and Stroke (NINDS) to Brian Kaspar, PhD, principal investigator in the Center for Gene Therapy at The Research Institute at Nationwide Children’s Hospital, will fund pre-clinical development of a new drug to fight spinal muscular atrophy (SMA). This agreement represents an innovative collaboration [...]

Read the full article →

FDA approves Lymphoseek for sentinel lymph node mapping

03.13.2013

The U.S. Food and Drug Administration today approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing surgery to remove tumor-draining lymph nodes. Lymphoseek is marketed by Navidea Biopharmaceuticals, based in Dublin, Ohio. Lymph nodes filter lymphatic [...]

Read the full article →

Dayton area emerging as another Ohio biomed cluster

03.11.2013

Dayton Daily News Reporter Tom Gnau shines some light on the Dayton area’s biomed cluster beginnings. Since he returned from a recent medical technology supplier conference in California, Mike Sieron’s phone has hardly stopped ringing. Sieron, president and chief executive of DG Medical in Centerville, says he can barely keep up with demand from customers [...]

Read the full article →

CWRU’s engineering school adds biomedical graduate tracks reflecting industry needs

03.07.2013

Case Western Reserve University’s School of Engineering has launched two new master’s degree programs that respond to shifts in the healthcare industry and workforce demand. The advanced degrees are aimed at professionals and recent graduates who seek specific training in wireless health or translational health technology. The class schedule caters to working engineers and scientists. The new [...]

Read the full article →

Phase II SBIR grant to fuel commercialization of Parkinson’s monitoring system

03.05.2013

Great Lakes NeuroTechnologies will be launching commercialization and clinical studies to validate a system for continuous monitoring of dyskinesias associated with Parkinson’s disease. The study is being funded by a $1,743,051 Phase II Small Business Innovative Research grant from the NIH National Institute on Aging. The technology will be developed and commercialized at Great Lakes [...]

Read the full article →

Ohio company’s Swiss parent inks manufacturing deal on insulin pump

03.04.2013

Swiss companies Valtronic and Debiotech have entered into an exclusive manufacturing partnership for Debiotech’s novel insulin pump called JewelPUMP. Valtronic’s U.S. headquarters are located near Cleveland. Using microfluidic MEMS (micro-electro-mechanical systems) technology in diabetes treatment, the watertight pump can be mounted on a disposable skin patch to provide continuous insulin infusion and is controlled by [...]

Read the full article →

Informatics may unlock next lung cancer treatment advancement

02.28.2013

Experts from The Ohio State University and University of Kentucky are collaborating to create a first of its kind biomedical informatics-based approach to help improve survival rates in people with lung cancer, the leading cancer killer among men and women in the U.S. The approach is combines two different areas of biomedical informatics—digital imaging and [...]

Read the full article →

Program that helps Ohio emerging bioscience companies is accepting new applicants

02.27.2013

BioEnterprise recently announced that Choose Ohio, a novel program designed to speed the growth of established life science companies in Ohio, is open for the Spring 2013 round of company submissions. Choose Ohio provides Ohio-based developers of life science products and services access to decision makers at Ohio’s leading medical centers, including Cleveland Clinic, Akron [...]

Read the full article →

Biosortia partners with Ohio State to discover anti-cancer compounds in nature

02.26.2013

The Ohio State University has signed a sponsored research agreement with Dublin, Ohio-based Biosortia Pharmaceuticals to uncover new biologically active natural products with potential anti-cancer activity. A division of Algaeventure Systems, Biosortia obtains unculturable aquatic microorganisms from the natural environment in unprecedented quantities for researchers to study. Potential candidate compounds discovered during the Biosortia-sponsored research project [...]

Read the full article →

← Previous Entries

Next Entries →